EMR Versus ESD for Barrett's Neoplasia

Rationale: The optimal technique for removal of visible dysplastic lesions in Barrett's esophagus remains controversial. Endoscopic mucosal resection (EMR) is safe, effective, easy to apply, and has been the most widely used technique since 2008. Endoscopic submucosal dissection (ESD) is a more controlled dissection method with potential improved efficacy, but at the cost of higher technical complexity. Objective: The investigators aim to compare EMR and ESD for removal of visible lesions in Barrett's esophagus. Study design: Randomized clinical trial Study population: Patients with Bar

Trial Details

NCT ID
NCT05276791
Phase
NA
Sponsor
St. Antonius Hospital
Status
RECRUITING
Cancer Type
Adenocarcinoma Esophageal Cancer
Interventions
  • EMR
  • ESD
Locations (sample)
  • Amsterdam, Netherlands|52.37403,4.88969
  • Eindhoven, Netherlands|51.44083,5.47778
  • Groningen, Netherlands|53.21917,6.56667
  • Nieuwegein, Netherlands|52.02917,5.08056
  • Rotterdam, Netherlands|51.9225,4.47917

Key Eligibility Criteria

  • Patients age: ≥ 18 years
  • Willingness to undergo both EMR or ESD
  • Ability to provide written, informed consent (approved by IRB) and understand the responsibilities of trial participation
  • BE with at least one visible lesion ("target lesion") with absence of signs of submucosal invasion on endoscopy, after evaluation by the adjudicati…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Adenocarcinoma Esophageal Cancer Trials on Trialify →